# Neuronal Subtype-Specific Expression of γ-Enolase: Its Role in Neuronal Differentiation

**Authors:** Selena Horvat, Urša Pečar Fonović, Nace Zidar, Bojan Doljak, Janko Kos, Anja Pišlar

PMC · DOI: 10.1007/s12017-025-08902-9 · 2026-01-30

## TL;DR

This study explores how γ-enolase, a glycolytic enzyme, supports the development of specific types of neurons, particularly cholinergic neurons, and how its activity is regulated by cathepsin X.

## Contribution

The study reveals that γ-enolase promotes neuronal differentiation, especially in cholinergic neurons, and is regulated by cathepsin X, offering new insights into neuroregeneration.

## Key findings

- γ-enolase expression is significantly upregulated in differentiated neurons, especially cholinergic-like neurons.
- Cathepsin X cleaves γ-enolase, reducing its neurotrophic effects, and inhibiting cathepsin X preserves active γ-enolase and promotes neuronal differentiation.
- A γ-enolase-derived peptide enhances neurite outgrowth and β-tubulin expression in cholinergic-like neurons.

## Abstract

Neuronal differentiation into specific subtypes is crucial for nervous system development and function, guided by neurotrophic factors. γ-Enolase, a neuron-specific glycolytic enzyme, exhibits neurotrophic-like properties and supports neuronal differentiation; however, its role in specific neuronal subtypes remains unknown. Here, we investigate the role of γ-enolase in differentiation dopaminergic-, cholinergic-, and adrenergic-like neuronal cells. Our results demonstrate that γ-enolase expression is significantly upregulated in differentiated cells, with the highest expression observed in cholinergic-like neurons. Full-length γ-enolase, compared to its truncated form, promoted enhanced neurite outgrowth and increased β-tubulin, a cytoskeletal marker. Conversely, silencing endogenous γ-enolase significantly reduced neurite length, confirming its essential role in driving neuronal morphological maturation. Furthermore, a γ-enolase-derived peptide corresponding to the active C-terminus of γ-enolase significantly promoted neurite outgrowth and increased β-tubulin expression, particularly in cholinergic-like neuronal cells. Notably, γ-enolase activity is regulated by cathepsin X, a lysosomal peptidase that cleaves γ-enolase at its C-terminus, reducing its neurotrophic effects. Confocal microscopy revealed increased co-localization of γ-enolase and cathepsin X in differentiated neuronal cells, emphasizing their interaction in cholinergic-like neurons. Inhibiting cathepsin X preserved active γ-enolase, promoted neuronal differentiation, and altered cytoskeletal marker expression. These findings suggest an important role for γ-enolase in cholinergic-like neuronal cells and propose cathepsin X as a regulatory modulator of γ-enolase activity, suggesting novel therapeutic strategies for neuroregeneration.

The online version contains supplementary material available at 10.1007/s12017-025-08902-9.

## Full-text entities

- **Genes:** PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, Adra2a (adrenergic receptor, alpha 2a) [NCBI Gene 11551] {aka Adra-2, Adra-2a, alpha(2A)AR, alpha2-C10, alpha2A, alpha2A-AR}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 5295] {aka AGM7, GRB1, IMD36, p85, p85-ALPHA, p85alpha}, Th (tyrosine hydroxylase) [NCBI Gene 21823], GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, Chat (choline O-acetyltransferase) [NCBI Gene 12647] {aka B230380D24Rik, CHOACTase}, ADRA2A (adrenoceptor alpha 2A) [NCBI Gene 150] {aka ADRA2, ADRA2R, ADRAR, ALPHA2AAR, FPLD8}, Ache (acetylcholinesterase) [NCBI Gene 11423], ENO1 (enolase 1) [NCBI Gene 2023] {aka ENO1-IT1, ENO1L1, HEL-S-17, MPB1, NNE, PPH}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, SNTG1 (syntrophin gamma 1) [NCBI Gene 54212] {aka G1SYN, SYN4}, ACHE (acetylcholinesterase (Yt blood group)) [NCBI Gene 43] {aka ACEE, ARACHE, N-ACHE, YT}, NTRK2 (neurotrophic receptor tyrosine kinase 2) [NCBI Gene 4915] {aka DEE58, EIEE58, GP145-TrkB, OBHD, TRKB, trk-B}, Eno1 (enolase 1, alpha non-neuron) [NCBI Gene 13806] {aka Eno-1, MBP-1, NNE}, Ctsz (cathepsin Z) [NCBI Gene 64138] {aka CTSX, D2Wsu143e}, BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}, Eno2 (enolase 2, gamma neuronal) [NCBI Gene 13807] {aka D6Ertd375e, Eno-2, NSE}, ENO2 (enolase 2) [NCBI Gene 2026] {aka HEL-S-279, NSE}, CTSZ (cathepsin Z) [NCBI Gene 1522] {aka CTSX}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, NTRK1 (neurotrophic receptor tyrosine kinase 1) [NCBI Gene 4914] {aka MTC, TRK, TRK1, TRKA, Trk-A, p140-TrkA}, CHAT (choline O-acetyltransferase) [NCBI Gene 1103] {aka CHOACTASE, CMS1A, CMS1A2, CMS6}
- **Diseases:** degeneration of dopaminergic neurons (MESH:D009410), cytotoxicity (MESH:D064420), bradykinesia (MESH:D018476), Cholinergic (MESH:C535672), neuroinflammatory (MESH:D000090862), neuroblastoma (MESH:D009447), post-traumatic stress disorder (MESH:D013313), neurodegeneration (MESH:D019636), psychiatric disorders (MESH:D001523), tremors (MESH:D014202), anxiety (MESH:D001007), Parkinson's disease (MESH:D010300), Alzheimer's disease (MESH:D000544), depression (MESH:D003866), cognitive impairments (MESH:D003072)
- **Chemicals:** Abz-FEK(Dnp)-OH (-), phosphoenolpyruvate (MESH:D010728), glycine (MESH:D005998), bicarbonate (MESH:D001639), Alexa Fluor 647 (MESH:C569686), SDS (MESH:D012967), lipid (MESH:D008055), PMA (MESH:D013755), Alexa Fluor 488 (MESH:C000711379), DAPI (MESH:C007293), methanol (MESH:D000432), 6-hydroxydopamine (MESH:D016627), HCl (MESH:D006851), acetylcholine (MESH:D000109), dithiothreitol (MESH:D004229), 3,3',5,5'-tetramethylbenzidine (MESH:C021758), 2-mercaptoethanol (MESH:D008623), PBS (MESH:D007854), Lipofectamine (MESH:C086724), dbcAMP (MESH:D003994), CO2 (MESH:D002245), NaCl (MESH:D012965), RA (MESH:D014212), carbonate (MESH:D002254), Alexa Fluor 555 (MESH:C000608607), HEPES (MESH:D006531), H2SO4 (MESH:C033158), norepinephrine (MESH:D009638), 2-phosphoglycerate (MESH:C008885), streptomycin (MESH:D013307), EDTA (MESH:D004492), DMSO (MESH:D004121), paraformaldehyde (MESH:C003043), Triton X-100 (MESH:D017830), acetate (MESH:D000085), penicillin (MESH:D010406), Tween 20 (MESH:D011136), polyvinylidene difluoride (MESH:C024865), DPBS (MESH:C012939), F12 (MESH:C007782)
- **Species:** Cytomegalovirus (genus) [taxon 10358], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** Neuro-2a — Mus musculus (Mouse), Mouse neuroblastoma, Cancer cell line (CVCL_0470), S2E — Mus musculus (Mouse), Hybridoma (CVCL_C5DX), LA-N-2 — Homo sapiens (Human), Neuroblastoma, Cancer cell line (CVCL_1829), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232), S2O — Mus musculus (Mouse), Hybridoma (CVCL_C0ZA), S2F — Mus musculus (Mouse), Hybridoma (CVCL_C4BW), BL — Homo sapiens (Human), Melanoma, Cancer cell line (CVCL_U802), SH-SY5Y — Homo sapiens (Human), Neuroblastoma, Cancer cell line (CVCL_0019), S2C — Canis lupus familiaris (Dog), Canine mastocytoma, Cancer cell line (CVCL_1R44)

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12858592/full.md

---
Source: https://tomesphere.com/paper/PMC12858592